Cover Image
市場調查報告書

幹細胞銀行、儲存市場:規模、區分、趨勢

The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends

出版商 BIOINFORMANT WORLDWIDE, LLC 商品編碼 330701
出版日期 內容資訊 英文 62 Pages
訂單完成後即時交付
價格
Back to Top
幹細胞銀行、儲存市場:規模、區分、趨勢 The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends
出版日期: 2015年05月21日 內容資訊: 英文 62 Pages
簡介

本報告提供全球幹細胞銀行、儲存市場相關調查、目前幹細胞銀行市場規模、5年的市場規模資料、今後5年的市場規模預測、各種類的市場佔有率、主要產業企業,及更多的競爭環境分析等,系統性資訊。

第1章 簡介

第2章 調查範圍

第3章 本調查的目的

第4章 調查手法

第5章 被保存的幹細胞的用途 (最終用途)

  • 生物銀行
  • 醫療用途
  • 科學用途

第6章 幹細胞生物銀行市場市場規模

  • 幹細胞儲存的年度收益:各市場區隔
  • 幹細胞儲存市場市場規模

第7章 幹細胞生物銀行市場基底變數

  • 幹細胞樣品的大約保存期間
  • 溫度必要條件
  • 邏輯的變數

第8章 產業的領導企業

  • 產業的領導企業保存的幹細胞的主要類型
  • 產業的領導企業所提供的基本服務分析

第9章 市場佔有率的明細:各用戶

第10章 市場特徵附有

  • 「專門」儲存企業及整體市場佔的儲存比例
  • 幹細胞生物銀行 (儲存) 市場百分比 (vs. 相關服務)

第11章 市場規模的成長率:5年資料分析的嘗試、5年預測

  • 全球分析
  • 北美分析

附錄

目錄

The purpose of this global strategic report is to prepare executives, company management, and industry investors with the data and knowledge necessary to make informed, educated decisions about commercial opportunities within the stem cell biobanking market.

This global strategic report is produced for:

  • Executives of Industrial-Scale Biobanks
  • Management of Stem Cell Product Companies
  • Management of Stem Cell Therapy Companies
  • Biobanking Industry Investors

It is designed to increase your efficiency and effectiveness in:

  • 1.Effectively pricing stem cell biobanking services
  • 2.Increasing revenue from stem cell biobanking services
  • 3.Identifying new or adjunct stem cell biobanking services to offer
  • 4.Identifying current market leaders within the stem cell biobanking market
  • 5.Characterizing the competitive environment for the stem cell biobanking market
  • 6.Identifying threats and opportunities within the stem cell biobanking market
  • 7.Acquiring greater market within the stem cell biobanking market
  • 8.Making intelligent investment decisions within the stem cell biobanking market

OVERVIEW

Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into mature cell types. Stem cells are still a relatively new discovery, as the first mouse embryonic stem cells were derived from embryos in 1981, but it was not until 1995 that the first culturing of embryonic stem cells from non-human primates occurred. Induced pluripotent stem cells were not produced until 2006. As a result of these discoveries, stem cells can now be derived at various points during the life cycles.

The following are stages during which stem cells can be derived:

  • Embryonic stem cells, derived from blastocysts
  • Fetal stem cells, obtained from fetuses
  • Post-natal stem cells derived from newborn tissues, including cord blood stem cells from umbilical tissue
  • Adult stem cells found in adult tissues, including hematopoietic stem cells, mesenchymal stem cells, and neural stem cells
  • Induced pluripotent stem cells, reprogrammed from adult cells
  • Cancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body
  • And more

Forces Driving the Stem Cell Biobanking Market

Stem cell research and experimentation is largely driven by the unique ability of stem cells to divide and replicate repeatedly. In addition, their "unspecialized" nature allows them to differentiate into a wide variety of specialized cell types. In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem and progenitor cells act as a repair system for the body, replenishing specialized cells.

Therefore, the possibilities arising from these characteristics have resulted in great commercial interest, with potential applications ranging from the use of stem cells in reversal and treatment of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, and more. Huntington's disease, Parkinson's disease, and spinal cord injuries are examples of conditions for which clinical applications involving stem cells could offer benefits in halting or even reversing adverse effects.

However, to have stem cells easily accessible for research purposes and clinical applications requires them to be preserved in stable, temperature controlled conditions.

For this reason, a substantial market has evolved for the biobanking of tissues containing stem cell populations and the storage of stem cells themselves.

Stem Cell Biobanking Market

Stem cell biobanking is the cryogenic storage of stem cells, or biological samples containing stem cells, for later use. The market for these services is known as the "Stem Cell Biobanking Market." Because stem cell biobanking often involves the long-term storage of stem cell samples, the market is sometimes is also known as the "Stem Cell Storage Market." For purposes of this analysis, these two terms are considered to be synonymous. A definition of this market is provided below.

Stem Cell Biobanking Market: The stem cell biobanking market is defined as the total annual revenue derived from the storage of:

  • 1. Stem cell lines and their derivatives
  • 2. All biological samples that were collected specifically because they contain stem cell populations (e.g. cord blood, adipose tissue, and more)

This report aims to understand and characterize the competitive environment for the stem cell biobanking market. As such, the research is focused on identifying leading participants in the stem cell storage market, distinguishing their business model, and exploring their relative market share.

Currently, the four leading providers of biobanking services are: Fisher Bioservices, Biostorage Technologies, EPL Archives, and Precision Bioservices. All four companies store millions of biological samples (15 million by Precision Bioservices, up to 170 million by Fisher Bioservices) and provide a diverse set of biobanking services. All but Precision Biosciences are multi-national companies with both U.S. and European operations. Because each company has large market share within the stem cell biobanking market, they are explored in detail within this report.

However, there are also companies specializing exclusively in stem cell storage. In one landmark event, Cellular Dynamics International (CDI) and the Coriell Institute for Medical Research announced receiving multi-million dollar grants from the California Institute for Regenerative Medicine (CIRM) for the creation of induced pluripotent stem cell (iPSC) lines from 3,000 healthy and diseased donors. CIRM awarded CDI $16 million to create three iPSC lines for each of 3,000 healthy and diseased donors and awarded the Coriell Institute $10 million to set up and biobank the iPSC lines. The result will be thecreation of the world's largest human iPSC bank, an incredible feat.

This iPSC biobank is one example of the expanding market for stem cell biobanking services. Because the goal of stem cell biobanking is to create a repository of stem cell specimens - including source tissue from which stem cells can be derived, differentiated cell types produced, and disease-specific cell lines created - large-scale stem cell biobanks provide researchers with the opportunity to investigate a diverse range of conditions using stem cells derived from both healthy and diseased donors. Importantly, biobanks can greatly expand the capacity for global research and collaboration.

Key report findings include:

  • Current Size of the Stem Cell Biobanking Market
  • Trailing 5-Year Market Size Data (2011-2015)
  • 5-year Market Size Projections (2016-2020)
  • Market Segmentation
  • Market Share by Segment
  • Key Industry Leaders
  • Detailed Competitive Environment Analysis
  • Analysis of Stem Cell Storage Applications (End-Uses)
  • Number of Stem Cell Samples Banked, by Industry Leader
  • Identification of Opportunities within the Stem Cell Biobanking Market
  • And Much More

Competing within the stem cell biobanking market can involve complicated and confusing decisions, but it doesn't need to. Claim this global strategic report to quickly understand current and future trends within the stem cell biobanking marketplace, identify opportunities by market segment, and derive more revenue from your stem cell biobanking services.

Table of Contents

1. INTRODUCTION

  • 1.1. Definitions
  • 1.2. Stem Cell Biobanking Market
  • 1.3. Stem Cell Biobanking Market Segments
    • TABLE: Stem Cell Biobanking Market Segments
  • 1.4. Stem Cell Biobanking Market Leaders

2. SCOPE

3. GOALS OF REPORT

4. METHODOLOGY

  • 4.1. Input Sources
  • 4.2. Research & Analysis Methodologies

5. APPLICATIONS FOR STORED STEM CELLS (END-USES)

  • 5.1. Biobanking
    • 5.1.1. Cord Blood Banking
      • IMAGE: Comparison of Umbilical Cord Blood vs. Umbilical Cord Tissue
    • 5.1.2. Bone Marrow & Peripheral Blood Specimens
    • 5.1.3. Dental Stem Cell Storage
      • TABLE: Companies Offering Dental Stem Cell Storage
    • 5.1.4. Adipose-Derived Stem Cell Storage
      • IMAGE: Companies Offering Adipose-Derived Stem Cell Storage
    • 5.1.5. Amniotic Fluid Storage
    • 5.1.6. Storage of Assisted Reproduction Specimens
  • Medical Applications
    • Cellular Therapy
    • Regenerative Medicine
    • Tissue Engineering
    • Personalized Therapeutics
  • Scientific Research
    • Basic Research
    • Applied Research

6. MARKET SIZE DETERMINATIONS FOR THE STEM CELL BIOBANKING MARKET

  • 6.1. Annual Revenue from Stem Cell Storage, by Market Segment
    • TABLE: Annual Revenue from Stem Cell Storage, by Market Segment
    • GRAPH: Annual Revenue from Stem Cell Storage, by Market Segment
  • Market Size Determinations for the Stem Cell Storage Market
    • Global Market Size
    • North American Market Size

7. BASIC VARIABLES FOR THE STEM CELL BIOBANKING MARKET.

  • Approximate Length of Time Stem Cell Samples are Stored
    • TABLE: Storage Durations, by Market Segment
  • Temperature Requirements
    • TABLE: Temperature Requirements for Stem Cell Biobanking
  • Logistical Variables

8. INDUSTRY LEADERS.

  • 8.1. Key Types of Stem Cells Stored by Industry Leaders
    • GRAPH: Stem Cell Biobanking Market - Market Share by Industry Leader
    • 8.1.1. Fisher BioServices
    • 8.1.2. BioStorage Technologies
    • TABLE: Range of Cryogenic Services Offered by BioStorage Technologies
    • 8.1.3. EPL Archives
    • TABLE: Range of Cryogenic Services Offered by EPL Archives
    • 8.1.4. Precision Bioservices
    • TABLE: Range of Cryogenic Services Offered by Precision Bioservices
  • 8.2. Analysis of Fundamental Services Provided by Industry Leaders (Storage, Logistics, Scientific
    • Services, Other)
    • Fisher BioServices
    • BioStorage Technologies
    • EPL Archives
    • Precision Bioservices

9. BREAKDOWN OF MARKET SHARE, BY CUSTOMER.

  • Graph: Stem Cell Biobanking Market - Breakdown of Market Share by End-User

10. MARKET CHARACTERIZATION

  • 10.1. "Pure Play" Storage Companies and Percentage of Total Market as Storage
    • TABLE: Market Segments for Stem Cell Storage, by End-User
  • 10.2. Percentage of Stem Cell Biobanking Market that is Storage (versus Related Services)
    • TABLE: Breakdown of Stem Cell Biobanking Market: Storage vs. Related Services
    • GRAPH: Breakdown of Stem Cell Biobanking Market: Storage vs. Related Services

11. MARKET SIZE GROWTH RATE DETERMINATIONS - TRAILING 5-YEAR DATA AND 5-YEAR PROJECTIONS (2016-2020)

  • 11.1. Global Analysis
    • TABLE: Trailing 5-Year Market Size Determinations for Global Stem Cell Biobanking Market (2011-2015)
    • GRAPH: Trailing 5-Year Market Size Determinations for Global Stem Cell Biobanking Market (2011-2015)
    • TABLE: 5-Year Projections for Global Stem Cell Biobanking Market (2016-2020)
    • GRAPH: 5-Year Projections for Global Stem Cell Biobanking Market (2016-2020)
  • 11.2. North American Analysis
    • TABLE: Trailing 5-Year Market Size Determinations for North American Stem Cell Biobanking Market (2011-2015)
    • GRAPH: Trailing 5-Year Market Size Determinations for North American Stem Cell Biobanking Market (2011-2015)
    • TABLE: 5-Year Projections for N. American Stem Cell Biobanking Market (2016-2020)
    • GRAPH: 5-Year Projections for N. American Stem Cell Biobanking Market (2016-2020)

APPENDICES

  • APPENDIX A - Complete List of Stem Cell Types
  • APPENDIX B - Global List of Biobanks and Biorepositories, by Geographical Region.
    • European Biobanks
    • North American Biobanks
    • United States Biobanks
    • Asian Biobanks
    • Australian Biobanks
    • Middle Eastern Biobanks
Back to Top